Company

SK Biopharmaceuticals

South Korea

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold SK Biopharmaceuticals?

Held by 37 covered funds. Sorted by SK Biopharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

Fund	Category	Share of fund
IBRNiShares Neuroscience and Healthcare	Genomics & Biotech Innovation	2.3%
EWYiShares MSCI South Korea	Technology	0.1%
FLKRFranklin FTSE South Korea	South Korea	0.1%
ESGEiShares ESG Aware MSCI Em	ESG & Sustainability	0.1%
DFSEDimensional Emerging Markets Sustainability Core 1	ESG & Sustainability	0.1%
DEHPDimensional Emerging Markets High Profitability	Asia-Pacific	0.0%
IDHQInvesco S&P International Developed Quality		0.0%
WRNDNYLI Global Equity R&D Leaders		0.0%
DEXCDimensional Emerging Markets ex China Core Equity		0.0%
XSOEWisdomTree Emerging Markets ex-State-Owned Enterprises Fund	Asia-Pacific	0.0%
FLAXFranklin FTSE Asia ex Japan	Asia-Pacific	0.0%
VPLVanguard Pacific Stock Index Fund	Asia-Pacific	0.0%
EEMAiShares MSCI Emerging Markets Asia	Asia-Pacific	0.0%
BKEMBNY Mellon Emerging Markets Equity	Asia-Pacific	0.0%
EMXCiShares MSCI Emerging Markets Ex China		0.0%
DFAEDimensional Emerging Core Equity Market	Asia-Pacific	0.0%
IEMGiShares Core MSCI Emerging Markets	Asia-Pacific	0.0%
DFEMDimensional Emerging Markets Core Equity 2	Asia-Pacific	0.0%
EEMiShares MSCI Emerging Markets	Asia-Pacific	0.0%
TLTEFlexShares Morningstar Emerging Markets Factor Tilt Index Fund		0.0%
AVSEAvantis Responsible Emerging Markets Equity	ESG & Sustainability	0.0%
SCHFSchwab International Equity		0.0%
VEAVanguard Developed Markets Index Fund		0.0%
VDGVanguard Developed Markets Ex-US Growth Index		0.0%
DFAXDimensional World ex U.S. Core Equity 2		0.0%
TEMUXEmerging Markets Equity Fund		0.0%
VSGXVanguard ESG International Stock	ESG & Sustainability	0.0%
AVENXAvantis Emerging Markets Equity Fund	Asia-Pacific	0.0%
VXUSVanguard Total International Stock Index Fund		0.0%
AVXCAvantis Emerging Markets ex-China Equity		0.0%
IXUSiShares Core MSCI Total International Stock		0.0%
VDVVanguard Developed Markets Ex-US Value Index		0.0%
VEUVanguard FTSE All-World Ex-US Index Fund		0.0%
SSGVXState Street Global All Cap Equity ex-U.S. Index Portfolio		0.0%
AVEMAvantis Emerging Markets Equity	Asia-Pacific	0.0%
SPDWSPDR Portfolio Developed World ex- US		0.0%
VTVanguard Total World Stock Index Fund		0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest SK Biopharmaceuticals news

No recent stories about SK Biopharmaceuticals.